Cardurion Pharmaceuticals
PrivateLast Round
Series B
Jul 16, 2024
Total Funding Raised
$631.8M
Company Overview
Cardurion Pharmaceuticals is a biotechnology company that develops innovative cardiovascular therapeutics aimed at treating heart diseases and preventing related complications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cardurion Pharmaceuticals Comparables
Compare Cardurion Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AnaCardio | 77% | |
| Windtree Therapeutics, Inc. | 77% | |
| Cytokinetics, Incorporated | 72% | |
Cardurion Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 16, 2024 | ||||
| Series A Extension | Dec 30, 2022 | ||||
| Private Equity | Oct 27, 2021 | ||||
| Series A | Nov 20, 2019 | ||||
| Seed | Aug 3, 2017 | ||||
Seed | Apr 4, 2017 |
Key People
Founding team and executive leadership
Cardurion Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Owl Rock Capital Group | Series B |
| Bain Capital Life Sciences | Series B, Private Equity |
| Farallon Capital Management | Series B |
| GV | Series B |
| Digitalis Ventures | Series B |
| New Enterprise Associates (NEA) | Series B |
| Millennium Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 20, 2025
Karen Lewis joins as Chief People Officer.
- Jan 8, 2025
Charlotte Newman joins as Chief Business Officer.
Cardurion Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cardurion Pharmaceuticals's valuation, stock price, and market status.